Corner Ally Ventures

Corner Therapeutics is a clinical-stage biotechnology company dedicated to developing a new class of immunotherapies that induce robust and durable protective immunity. The company's proprietary Cornerstone platform is designed to program dendritic cells to activate both memory and naive T cells, mimicking the natural immune response to infection. By targeting the fundamental mechanisms of immune memory, Corner Therapeutics aims to create highly effective vaccines and treatments for cancer, infectious diseases, and inflammatory conditions. The company is led by a team of experienced scientists and industry veterans focused on transforming the landscape of immunotherapy through precision immune modulation.